美国放射学会乳腺影像报告和数据系统第4类细分在诊断性乳腺X线摄影中的应用与转归:国家乳腺X线摄影数据库分析
该研究回顾性分析2008年1月1日至2014年12月30日国家乳腺X线摄影数据库中1309950例诊断性乳腺X线摄影,其中125447例(9.6%)为BI-RADS第4类,仅33.3%(41841/125447)进行了细分。细分后4A、4B、4C的PPV3分别为7.6%(1274/16784)、22%(2317/10408)、69.3%(2839/4099),均位于BI-RADS规定的恶性范围;作者认为该分析支持在广泛实践中使用细分,并应促使提高使用率。
要点
- 诊断性乳腺X线摄影中BI-RADS第4类仅33.3%进行了细分。
- 细分后4A、4B、4C的PPV3分别为7.6%、22%、69.3%。
- 细分使用率在社区、郊区、西部机构及有乳腺癌病史者中更高;结构扭曲征象使用率更高。
核心结论
- 尽管BI-RADS建议使用细分,但第4类诊断性乳腺X线摄影中仅少数(33.3%[41841/125447])进行了细分,且使用率因机构和检查特征而异;细分后PPV3位于BI-RADS规定的恶性范围,该分析支持在广泛实践中使用细分,并应促使提高使用率。
研究设计与样本
- 回顾性分析国家乳腺X线摄影数据库2008年1月1日至2014年12月30日提交的诊断性乳腺X线摄影数据,共1309950例,其中第4类125447例(9.6%),细分41841例(33.3%)。
诊断标准与关键数值
- 第4类总体PPV3为21.1%(19285/91563);4A的PPV为7.6%(1274/16784),4B的PPV为22%(2317/10408),4C的PPV为69.3%(2839/4099),不同细分间PPV3差异有统计学意义(P < .001)。
临床应用与阅片要点
- 作者认为该分析支持在广泛实践中使用细分,并鉴于对患者护理的益处应促使提高使用率;细分使用率在社区、郊区或西部机构、有乳腺癌病史的检查指征以及结构扭曲影像征象中更高(P < .001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involved retrospective review of diagnostic mammography data submitted to the NMD from January 1, 2008 to December 30, 2014. Utilization rates of BI-RADS category 4 subdivisions were compared by year, facility (type, location, census region), and examination (indication, finding type) characteristics. PPV3 (positive predictive value for biopsies performed) was calculated overall and according to category 4 subdivision. The χ2 test was used to test for significant associations. Results Of 1 309 950 diagnostic mammograms, 125 447 (9.6%) were category 4, of which 33.3% (41 841 of 125 447) were subdivided. Subdivision utilization rates were higher (P < .001) in practices that were community, suburban, or in the West; for examination indication of prior history of breast cancer; and for the imaging finding of architectural distortion. Of 41 841 category 4 subdivided examinations, 4A constituted 55.6% (23 258 of 41 841) of the examinations; 4B, 31.8% (13 302 of 41 841) of the examinations; and 4C, 12.6% (5281 of 41 841) of the examinations. Pathologic outcomes were available in 91 563 examinations, and overall category 4 PPV3 was 21.1% (19 285 of 91 563). There was a statistically significant difference in PPV3 according to category 4 subdivision (P < .001): The PPV of 4A was 7.6% (1274 of 16 784), that of 4B was 22% (2317 of 10 408), and that of 4C was 69.3% (2839 of 4099). Conclusion Although BI-RADS suggests their use, subdivisions were utilized in the minority (33.3% [41 841 of 125 447]) of category 4 diagnostic mammograms, with variability based on facility and examination characteristics. When subdivisions were used, PPV3s were in BI-RADS-specified malignancy ranges. This analysis supports the use of subdivisions in broad practice and, given benefits for patient care, should motivate increased utilization. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Elezaby M, Li G, Bhargavan-Chatfield M, et al. ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database. Radiology. 2018. PMID: 29315061. doi:10.1148/radiol.2017170770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。